August 12 Product: Sandozs Enzeevu Indication: Neovascular age-related macular degeneration Sandoz bolstered its biosimilar position in the ophthalmology space Monday with an approval for Enzeevu, a 2-mg vial kit and prefilled syringe for intravitreal injection to treat neovascular age-related macular degeneration (nAMD)
Sinead Bradbury MSc, Senior Performance Nutritionist Sinad is a leading Performance Nutritionist with over 15 years of experience helping athletes, teams, and organisations optimise energy, health, and performance
On GLP-1 medications, with slowed motility, they often trigger noticeable bloating, cramps, and discomfort
Available at: (Accessed October 20, 2024)
Role of Behavioral Interventions in the Management of Obesity
Homocysteine: A Signal, Not Just a Toxin Homocysteine is a natural byproduct of protein metabolism